These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7694238)

  • 1. Pacemaker and implantable cardioverter defibrillator electrocardiography.
    Furman S
    Pacing Clin Electrophysiol; 1993 Oct; 16(10):1943-4. PubMed ID: 7694238
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on Cardiovascular Implantable Electronic Devices for Anesthesiologists.
    Cronin B; Essandoh MK
    J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1871-1884. PubMed ID: 29217253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative Interrogation of Boston Scientific Cardiovascular Implantable Electronic Devices: A Guide for Anesthesiologists.
    Cronin B; Birgersdotter-Green U; Essandoh MK
    J Cardiothorac Vasc Anesth; 2019 Apr; 33(4):1076-1089. PubMed ID: 29929895
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter regarding article by Roguin et al, "Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 t".
    Sommer T; Naehle CP
    Circulation; 2005 Jun; 111(23):e391; author reply e391-2. PubMed ID: 15959929
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter regarding article by Roguin et al, "Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 t".
    Vahlhaus C
    Circulation; 2005 Jun; 111(23):e390-1; author reply e391-2. PubMed ID: 15959928
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter regarding article by Roguin et al, "Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 t".
    Chen-Scarabelli CA; Scarabelli TM
    Circulation; 2005 Jun; 111(23):e390; author reply e391-2. PubMed ID: 15956143
    [No Abstract]   [Full Text] [Related]  

  • 7. Tune-ups. Implantable cardiac device manufacturers are looking for better ways to monitor their products' functionality. But is it making a difference?
    Mettner J
    Minn Med; 2006 Nov; 89(11):12-3. PubMed ID: 17153893
    [No Abstract]   [Full Text] [Related]  

  • 8. Critical pathway for management of pacemaker and implantable cardioverter-defibrillator advisories.
    Amin MS; Ellenbogen KA
    Crit Pathw Cardiol; 2007 Mar; 6(1):1-4. PubMed ID: 17667879
    [No Abstract]   [Full Text] [Related]  

  • 9. Purchasing implantable pacemakers. Part 2: The implantable pacemaker market.
    Health Devices; 1996 Sep; 25(9):326-37. PubMed ID: 8878725
    [No Abstract]   [Full Text] [Related]  

  • 10. Legal implications of pacemaker and defibrillator guidelines.
    Böcker D; Gradaus R; Köbe J; Wollmann CG; Breithardt G; ;
    Card Electrophysiol Rev; 2003 Jan; 7(1):33-5. PubMed ID: 12766514
    [No Abstract]   [Full Text] [Related]  

  • 11. Preoperative evaluations: the very last chance to identify a problem with a pacemaker or implanted cardioverter-defibrillator.
    Rozner MA
    J Cardiothorac Vasc Anesth; 2008 Jun; 22(3):341-6. PubMed ID: 18503919
    [No Abstract]   [Full Text] [Related]  

  • 12. Permanent pacing via implantable defibrillators.
    Pinski SL; Trohman RG
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 1):1667-82. PubMed ID: 11138305
    [No Abstract]   [Full Text] [Related]  

  • 13. Defibrillator/monitor/pacemakers: our latest look at what's on the market.
    Health Devices; 2007 Jul; 36(7):214-31. PubMed ID: 17802677
    [No Abstract]   [Full Text] [Related]  

  • 14. Remote follow-up and continuous remote monitoring, distinguished.
    Burri H
    Europace; 2013 Jun; 15 Suppl 1():i14-i16. PubMed ID: 23737223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface labeling on implantable pacemaker pulse-generators.
    Parsonnet V
    Pacing Clin Electrophysiol; 1998 Feb; 21(2):484. PubMed ID: 9507560
    [No Abstract]   [Full Text] [Related]  

  • 16. A completely subcutaneous implantable cardioverter defibrillator system functioning simultaneously with an endocardial implantable cardioverter defibrillator programmed as pacemaker.
    van Opstal J; Geskes G; Debie L
    Europace; 2011 Jan; 13(1):141-2. PubMed ID: 20587539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey.
    Marinskis G; van Erven L; Bongiorni MG; Lip GY; Pison L; Blomström-Lundqvist C;
    Europace; 2012 Mar; 14(3):423-5. PubMed ID: 22355191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance.
    Tjong FV; Brouwer TF; Smeding L; Kooiman KM; de Groot JR; Ligon D; Sanghera R; Schalij MJ; Wilde AA; Knops RE
    Europace; 2016 Nov; 18(11):1740-1747. PubMed ID: 26941338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique sensing errors in third-generation implantable cardioverter-defibrillators.
    Callans DJ; Hook BG; Kleiman RB; Mitra RL; Flores BT; Marchlinski FE
    J Am Coll Cardiol; 1993 Oct; 22(4):1135-40. PubMed ID: 8409053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of cardiac implantable devices in patients undergoing radiotherapy.
    Dobson R; Wright DJ
    Curr Probl Cancer; 2018 Jul; 42(4):443-448. PubMed ID: 30104031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.